Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Financings In Brief: IDEC Pharmaceuticals

Executive Summary

IDEC Pharmaceuticals: Net proceeds from 2.1 mil. share offering approximate $46 mil., the company announces June 12. The offering, consisted of 1.8 mil. shares plus an additional 270,000 shares in an over-allotment which underwriters Morgan, Stanley and Punk, Ziegel & Knoell exercised in full. Proceeds will be used to support development of the company's immune system products for the treatment of cancers, autoimmune and inflammatory diseases...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS028342

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel